Fasting-Mimicking Diet for Inflammatory Bowel Disease-Related Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a special diet that mimics fasting might benefit people with inflammatory bowel disease (IBD) who also experience depression. Participants will follow a plant-based fasting-mimicking diet, low in calories for five days each month, or another diet sufficient in calories, over three months. Researchers aim to determine if this dietary approach can improve gut health and reduce depression symptoms. This trial suits individuals with Crohn's disease or ulcerative colitis in mild or moderate stages, who also have mild to moderate depression. As an unphased trial, it offers a unique opportunity to explore innovative dietary approaches that could enhance quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that a fasting-mimicking diet might be safe for people with inflammatory bowel disease (IBD). In various studies, this diet has demonstrated potential in reducing gut inflammation and improving gut health. For instance, some research found that following a fasting-mimicking diet in cycles reduced inflammation and even helped repair gut tissue in mice with IBD.
Another study showed that this diet decreased intestinal inflammation and increased the number of intestinal stem cells, which are crucial for maintaining a healthy gut lining. These findings suggest that the diet is generally well-tolerated and may offer benefits without major side effects.
While these studies are promising, it is important to note that most findings come from animal research. Human studies are still needed to confirm these effects. However, current evidence suggests that a fasting-mimicking diet is generally safe for trial participants.12345Why are researchers excited about this trial?
Researchers are excited about the fasting-mimicking diet for inflammatory bowel disease-related depression because it offers a unique, dietary approach that could complement or even reduce reliance on traditional medication. Unlike standard treatments that typically involve medications like antidepressants or anti-inflammatory drugs, this diet mimics fasting, potentially reducing inflammation and improving mood through natural, plant-based means. Additionally, the diet is only followed for five days each month, providing a manageable and less intrusive lifestyle change for participants. This novel approach taps into the body's natural processes, which might lead to fewer side effects and a holistic improvement in well-being.
What evidence suggests that this trial's treatments could be effective for IBD-related depression?
Research has shown that a diet similar to fasting can affect gut health, potentially reducing depression in people with inflammatory bowel disease (IBD). In this trial, participants will join one of two treatment arms. One group will follow a plant-based fasting-mimicking diet, while the other will adhere to a plant-based caloric-sufficient diet. Studies have found that a fasting-mimicking diet can alter the gut microbiome, the group of bacteria living in the intestines, to improve gut health and lower inflammation. This is significant because inflammation and gut bacteria are linked to both IBD and depression. Early findings suggest that a fasting-like diet might enhance mental health by fostering a healthier gut environment. Although more research is needed, the initial results are promising for those with depression related to IBD.16789
Who Is on the Research Team?
Karen Madsen, PhD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with Crohn's disease or ulcerative colitis in remission, who are experiencing mild to moderate depression. They must not be underweight, malnourished, have a severe illness like AIDS or cancer, be pregnant or breastfeeding, have had certain gastrointestinal surgeries, suffer from diabetes or celiac disease, nor have a history of psychotic disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants are followed for baseline assessment before starting the diet intervention
Treatment
Participants consume a plant-based fasting-mimicking diet or a caloric-sufficient diet for 5 days once a month for 3 months
Follow-up
Participants are monitored for changes in depressive symptoms, gut microbiome, and other health markers
What Are the Treatments Tested in This Trial?
Interventions
- Plant-based fasting-mimicking diet
Trial Overview
The study tests the effects of a fasting-mimicking diet on depressive symptoms in IBD patients. Participants will alternate between a low-calorie plant-based diet for 5 days and their normal diet for 3 weeks over several cycles. The focus is on how this diet affects gut microbes and mental health.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will be followed for 3 weeks for baseline assessment and then consume a plant-based fasting-mimicking diet for 5 days once a month for 3 months.
Participants will be followed for 3 weeks for baseline assessment and then consume a plant-based caloric-sufficient diet for 5 days once a month for 3 months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
W. Garfield Weston Foundation
Collaborator
Published Research Related to This Trial
Citations
Fasting-mimicking Diet in Treatment of Depressive Symptoms in ...
Changes in quality of Life, Changes in quality of life as assessed by Short Inflammatory Bowel Disease Questionnaire (SIBDQ) (score 10-70, poor to good), From ...
Fasting-Mimicking Diet for Inflammatory Bowel Disease ...
The object of this clinical trial is to investigate the effects of a fasting mimicking diet in IBD patients who are suffering with symptoms of depression.
Fasting-Mimicking Diet Modulates Microbiota and Promotes ...
Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology.
4.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT05382897/fasting-mimicking-diet-in-treatment-of-depressive-symptoms-in-ibdFasting-mimicking Diet in Treatment of Depressive ...
The object of this clinical trial is to investigate the effects of a fasting mimicking diet in IBD patients who are suffering with symptoms of ...
5.
studies.bethecure.ca
studies.bethecure.ca/find/26c39bac0cbf6c24f742c7cbad4708f8fe860252-effects-of-a-fasting-mimicking-diet-on-depressiFasting-mimicking Diet in Treatment of Depressive Symptoms ...
The object of this clinical trial is to investigate the effects of a fasting mimicking diet in IBD patients who are suffering with symptoms of depression.
Fasting-mimicking diet holds promise for treating people ...
Results showed that fasting-mimicking diet caused a reduction in intestinal inflammation and an increase in intestinal stem cells in part by ...
The Influence of a Fasting Mimicking Diet on Ulcerative ...
The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC).
Reduced-calorie diet lowers signs of inflammatory bowel ...
In the mice given cycles of the fasting-mimicking diet, gut inflammation and other signs of IBD improved. The researchers also observed that the ...
IBD: A low-calorie plant diet relieves inflammation, repairs gut
Cycles of a low-calorie, plant-based diet reduced inflammation, prompted tissue repair, and promoted good bacteria in intestines of mice ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.